Medical Device Network on MSN
Artivion treats first subject in trial of Arcevo LSA stent graft
Participants included in the trial have been diagnosed with either aortic dissection or aneurysm involving the aortic arch.
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback